Bruker (BRKR) Receivables - Other (2022 - 2026)

Bruker (BRKR) has reported Receivables - Other for 5 consecutive years, with $116.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Receivables - Other rose 3.2% year-over-year to $116.0 million; the trailing twelve-month figure through Jun 2026 stood at $116.0 million (up 3.2% YoY), and the FY2025 full-year result was $112.5 million, up 20.19% from the prior year.
• Receivables - Other fell to $116.0 million in Q2 2026 per BRKR's latest filing, from $118.2 million in the prior quarter.
• Across five years, Receivables - Other topped out at $118.6 million in Q3 2025 and bottomed at $60.8 million in Q4 2022.
• Historically, Receivables - Other has averaged $98.2 million across 5 years, with a median of $98.6 million in 2024.
• The sharpest annual moves came in 2023 and 2026: Receivables - Other soared 35.86% in 2023, then increased 3.2% in 2026.
• Over 5 years, Receivables - Other stood at $60.8 million in 2022, then jumped by 35.86% to $82.6 million in 2023, then advanced by 13.32% to $93.6 million in 2024, then increased by 20.19% to $112.5 million in 2025, then advanced by 3.11% to $116.0 million in 2026.
• According to Business Quant data, Receivables - Other over the past three periods registered $116.0 million, $118.2 million, and $112.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.